Meet Dr. Pravin Khemani
Movement Disorders Specialist in Dallas
Pravin Khemani, M.D., is fellowship-trained in movement disorders and neuromuscular diseases. He specializes in leading-edge care to treat Parkinson disease, ataxias, dystonia, Huntington’s disease, tremor, and other conditions classified as movement disorders.
Dr. Khemani brings a comprehensive approach to patient care at UT Southwestern Medical Center. In addition to the latest therapies, he offers a unique understanding of the support services his patients may need.
He says that addressing the holistic needs of each patient with a movement disorder is key to optimizing results. Beyond using his expertise to pinpoint the underlying causes of a disease, he listens closely to his patients and watches more than just their uncontrolled movements.
“A holistic approach involves not only using medicines, but other specialists – including the rehabilitation team, mental health experts, and surgeons when needed – to manage all troubling symptoms related to the disease,” he says. “That’s what I call multidisciplinary care.”
If patients need speech therapy for slurred speech, physical therapy for balance training, or counseling before deep brain stimulation, Dr. Khemani refers them to the right team member at UT Southwestern for the care they need.
He has a particular interest in treatment of ataxias, deep brain stimulation for Parkinson’s disease, and Botox injections for dystonia and spasticity.
Dr. Khemani is a leader in UT Southwestern’s active and successful Botox clinic to treat dystonia and spasticity. Patients are given injections every three to four months in the muscles that cause their uncontrolled movements or stiffness. He says it’s been highly effective in relieving symptoms and improving quality of life for patients.
As a clinician-educator, Dr. Khemani also teaches and mentors medical students, residents, and fellows. In his role as Medical Director of the Neurology clinic at Parkland Hospital, he is intimately involved in education of trainees and improving care of the underserved population.
Dr. Khemani is involved in clinical trials that complement the standard of care and explore future treatments. He has seen steady advancement in treatments for movement disorders and expects to see many more through research projects such as the identification of biomarkers in Parkinson’s disease and analysis of gait and balance in neurological disorders.